Tickerover
Healthcare

ELAN Stock Analysis

Elanco Animal Health Incorporated · current price $24.12 (-1.59% today)

Solid setup — 4/4 EPS beats. Momentum, fundamentals and macro indicators are aligned.
★★★★
Quality
📊

The six-pillar scorecard

Momentum
37
Losing steam
price trend
Growth
27
Barely growing
sales & profit growth
Quality
88
High quality
profitability & balance sheet
Valuation
35
Getting pricey
is the price fair?
Sentiment
67
Positive mood
analyst & crowd mood
Risk
54
Moderate risk
volatility & drawdown

Each pillar is scored 0-100 inside the stock’s own peer group, so a chipmaker is measured against chipmakers. These are quality descriptors, not buy or sell signals.

📉

The picture

What drove the scoreThe seven components contributing most, each read out of 100.
GrowthGrowth: 7878RSI zoneRSI zone: 7070Earnings qualityEarnings quality: 9393Relative strengthRelative strength: 6565Near 52w highNear 52w high: 8888Analyst consensusAnalyst consensus: 7070FundamentalsFundamentals: 6565
Margin profileWhat survives each step down the income statement.
GrossGross: 55.4%55.4%OperatingOperating: 8.6%8.6%NetNet: -4.0%-4.0%Free cash flowFree cash flow: 7.5%7.5%
EPS surpriseReported EPS against estimate, last four quarters.
2026-06: +26.5% vs estimate+26%2026-062026-03: +16.6% vs estimate+17%2026-032025-12: +11.2% vs estimate+11%2025-122025-09: +43.9% vs estimate+44%2025-09
👁

Hype Check

Reading ELAN’s price and volume history…

The audit — what has to hold for this thesis

Checking the areas that decide this thesis…

AI-generated from the company’s own filings and recent coverage, and it can be incomplete or wrong. A PASS is a reading of the cited evidence, not a verified fact and not a reason to buy. Follow each citation to the source.

🛡

Dilution Check

Reading ELAN’s filings…

📣

Latest earnings

LAST EARNINGS Elanco Animal Health Incorporated (ELAN)

Latest earnings

EPS
$0.19 vs $0.13 est · +43.9% vs estimate BEAT
Revenue
$1.37B · +20.3% YoY
Stock reaction (1M)
-8.9%
Beat streak
4 of last 4 quarters
💰

Valuation

P/E
18.8×
Forward P/E
18.8×
PEG
4.04
Price / Sales
2.4×
Price / Book
1.8×
EV / EBITDA
15.6×
Analyst target
$31.21
Target range
$26.00 – $34.00
Implied upside
+29.4%
🩺

Financial health

Gross margin
55.4%
Operating margin
8.6%
Net margin
-4.0%
FCF margin
7.5%
Return on equity
-3.0%
Debt / equity
0.64
Revenue growth YoY
+10.2%
EPS growth YoY
+4.4%
📈

Technicals

$17.1152-week range$27.98
RSI (14)
49
50-day MA
$24.60
200-day MA
$23.68
ATR (14)
0.76
Beta
1.69
1-month return
-8.9%
🗓️

Earnings

QuarterEPSEst.SurpriseResult
2025-09-30$0.19$0.13+43.9%Beat
2025-12-31$0.13$0.12+11.2%Beat
2026-03-31$0.40$0.34+16.6%Beat
2026-06-30$0.34$0.27+26.5%Beat
Beat 4 of the last 4 quarters.
🏛️

Ownership & risk

Short % of float
0.09%
Beta
1.69
📰

Latest news on ELAN

🔗

Similar stocks in Healthcare

Frequently asked

What is ELAN's Quant Score?

Elanco Animal Health Incorporated (ELAN) currently has a TickerMover Quant Score of 61/100, rated ★★★★ Quality. The Quant Score is a quantitative composite across six research pillars — momentum, quality, growth, valuation, sentiment and risk. It is research information, not investment advice.

Is Elanco Animal Health Incorporated (ELAN) a buy?

TickerMover does not give buy or sell recommendations. ELAN scores 61/100 (★★★★ Quality) on our quantitative research model — a screening signal, not a personal recommendation. Do your own research, and consider an FCA-authorised adviser before investing.

How often is ELAN's score updated?

ELAN's Quant Score and underlying data refresh through US market hours (about every five minutes), using public market and fundamental data.

Get the full live dashboard

Real-time scoring, conflict detection, Reverse DCF and peer comparison — free while in beta.

Open the dashboard for ELAN →